29.08.2019 • News

Clariant Expands Catalyst Output in China

Chief operating officer Hans Bohnen said the project supports Clariant’s...
Chief operating officer Hans Bohnen said the project supports Clariant’s strategy of focusing on its core high-value specialty businesses to intensify growth, especially in major growth markets such as Asia-Pacific, in particular China

Clariant is planning a “significant” expansion of its catalyst production in Panjin, Liaoning province, northeast China. The Swiss specialty chemicals producer said the double-digit million Swiss franc investment sum will cover further optimization of an existing facility and enable the creation of a new state-of-the-art production line for its SynDane maleic anhydride (MA) catalyst.

Chief operating officer Hans Bohnen said the project supports Clariant’s strategy of focusing on its core high-value specialty businesses to intensify growth, especially in major growth markets such as Asia-Pacific, in particular China. The Swiss group added that the upgrade will help its customers meet the “dynamically growing” global demand for MA, for which production is expected to jump from 1.75 million t/y in 2018 to 2.07 million t/y in 2022.

The SynDane catalysts are said to be optimized for cost-efficient MA production via selective oxidation of n-butane in fixed-bed tubular reactors. Clariant said the catalysts’ superior yield, selectivity and operating stability greatly reduce the formation of byproducts such as acrylic acid and acetic acid as well as their downstream polymerization, thus minimizing downtime for equipment.

Since 2007, Clariant has produced the MA catalysts at Panjin in a joint venture with leading Chinese petrochemical producer North Huajin Chemical Industries. The Panjin site employs more than 140 people producing catalysts and adsorbents for production of butane-based maleic anhydride, ammonia, hydrogen, and methanol, as well as for other applications.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.